Keith Chan

This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Panion & Bf Biotech Inc., Globoasia, LLC, Panion & Biotech Inc.. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Chan. Retrieved from https://idiyas.com/inventor/keith-chan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 8)

% Patents Active = 80.0

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 38(Granted Patents)

Company Filing History:

6 out of 17

Panion & Bf Biotech Inc.

Panion & Biotech Inc.

patent

Years Active: 2012-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10898459 - Method of treating chronic kidney disease (2021-01-26),

2. 9889113 - Method for reversing, preventing, delaying or stabilizing soft tissue calcification (2018-02-13),

3. 9757416 - Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same (2017-09-12),

4. 9750715 - Method of reversing, preventing, delaying or stabilizing soft tissue calcification (2017-09-05),

5. 9539284 - Method of selecting phosphate binder and its uses thereof (2017-01-10),

6. 9050316 - Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same (2015-06-09),

7. 8932648 - Method of selecting phosphate binder and its uses thereof (2015-01-13),

8. 8754257 - Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same (2014-06-17),

9. 8299298 - Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same (2012-10-30),

10. 8093423 - Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same (2012-01-10),

Title: The Innovative Contributions of Keith Chan

Introduction

Keith Chan is a prominent inventor based in Rockville, MD, known for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, Chan has focused on developing methods and compounds that address critical health issues, particularly in the treatment of chronic kidney disease and soft tissue calcification.

Latest Patents

Among his latest patents, Chan has developed a method for treating chronic kidney disease. This invention discloses pharmaceutical-grade ferric organic compounds that have an enhanced dissolution rate. These compounds, including ferric citrate, are particularly useful for treating chronic kidney disease. Additionally, he has patented a method for reversing, preventing, delaying, or stabilizing soft tissue calcification. This method involves administering an effective amount of ferric organic compound, such as ferric citrate, to treat soft tissue calcification in various parts of the body, including joints, skin, and internal organs.

Career Highlights

Throughout his career, Keith Chan has worked with notable companies such as Panion & Bf Biotech Inc. and Globoasia, LLC. His work in these organizations has allowed him to collaborate with other experts in the field and further his research and development efforts.

Collaborations

Some of his coworkers include Winston Town and David W K Kwok, who have contributed to his innovative projects and research initiatives.

Conclusion

Keith Chan's work exemplifies the impact of innovation in healthcare, particularly through his patents that address chronic kidney disease and soft tissue calcification. His contributions continue to advance the field and improve patient outcomes.

Profile summary based on public USPTO records.